Ketoreductases are among the most ubiquitous of microbial enzymes 1, 2 . Microbial ketoreductases have been extensively studied and utilized as biocatalysts for the asymmetric synthesis of a variety of chiral alcohols owing to their high stereoselectivity [3] [4] [5] [6] . While ketoreductases capable of reducing a single carbonyl group in a given substrate to form a chiral hydroxyl product is quite common, double reduction of a diketo ester by a single enzyme has not yet been well established. Reductions of β,δ-diketo esters could theoretically yield four stereoisomers from a diketo ester substrate. Stereoselective reductions of a β,δ-diketo-hexanoate ester have values in synthetic organic chemistry 1, [7] [8] , particularly in the preparation of diols, such as those found in the side chains of statins.
Diastereo-and enantioselective reductions of β,δ-diketo esters remains challenging in synthetic chemistry. Because of their intrinsic advantages of highly selective substrate binding leading to exceptional stereoselectivity under mild reaction conditions 7-9 , enzymatic transformations have emerged as versatile tools for organic synthesis. Given that optically pure β,δ-dihydroxy-hexanoate esters are important building blocks for statins -a class of effective cholesterol lowering therapeutics currently with the largest market in the world 9 , developing practical and more economic routes to β,δ-dihydroxyhexanoate esters has attracted widespread attention 7-9 .
In previous reports 10, 11 , multiple ketoreductases were purified in an Acinetobacter species. One isolated enzyme was suggested to have the potential to reduce diketo esters.
However, this enzyme appears to be different than any identified ketoreductases with known sequences. Unfortunately, such a unique reaction has not been clearly characterized biochemically or genetically.
In order to ascertain the existence of and exploit the unique characteristics of this type of enzymatic transformation, we screened a number of Acinetobacter sp. for the presence of diketoreductases using ethyl 3,5-diketo-6-benzyloxy-hexanoate (1) Fig. 1 ). After evaluation of different conditions, the protein was successfully expressed in soluble form by induction with 50 µM IPTG at 15 ˚C (Fig. 1C) . In the presence of NADH, the crude cell extract prepared from expressed E. coli cells directly reduced the 3,5-diketo ester (1) to corresponding dihydroxy ester (4) . rDKR was purified to homogeneity (Fig. 1C) by DEAE-sepharose and Sephadex-100 chromatography, to give a protein with a specific activity of 9.5 µmoles/min/mg protein. After enzymatic conversion, the dihydroxy product was isolated and characterized by 1 H NMR (Supplementary Table 1 ) and mass spectrometry ( Supplementary Fig. 2 ), and shown to be identical to reported data 10-11 .
Thus, we named this 30 kDa enzyme as diketoreductase (DKR) based on its catalytic characteristics. Purified rDKR shows a relatively broad pH optimum centered at pH 6.0
( Supplementary Fig. 3 ) and broad temperature optimum centered at about 40 ˚C ( Supplementary Fig. 4 ). rDKR retains more than 90% of activity after storage at 4 ˚C for two months. Through gel filtration, the natural form of the enzyme is a monomeric protein.
The fairly good stability of the DKR is possibly due to this structural characteristic.
To examine the stereoselectivity of the rDKR and to compare it with wild type strain, we performed a biocatalytic conversion using the 3,5-diketo ester (1) as substrate with
A. baylyi ATCC 33305 cells and purified rDKR with NADH. After 18 hours, the diastereomeric and enantiomeric excesses of the isolated products were evaluated by our chiral reverse phase high performance liquid chromatography (HPLC) method 15 .
Compared to the HPLC chromatogram of the isomeric mixture of ethyl 3,5-dihydroxy-6-benzyloxy-hexanoate obtained by chemical reduction (Fig 2A) , the product produced by whole cell reaction of A. baylyi ATCC 33305 showed a major peak for the (3R,5S)-stereoisomer along with peaks for (3S,5R)-and (3R,5R)-stereoisomers, indicating a de value of 66% and an ee value of 99% 10 . The dihydroxy ester produced by rDKR exhibited only a peak of (3R,5S)-stereoisomer (Fig. 2B) (Fig. 3A) . The reaction was much slower using NADPH and a regeneration system of glucose-6-phosphate: glucose-6-phosphate Generally, A. baylyi ATCC 33305 has been regarded as a pathogenic organism, but little is known on the mechanism of its virulence [24] [25] [26] [27] . So far, secondary metabolism in this organism also remains unexplored. From the present study, we speculate that DKR may play a role in the biosynthesis of secondary metabolites in this organism 28 since the double reduction of the carbonyl groups in a diketohexanoate ester molecule by a single enzyme is not involved in any primary metabolisms, which will be the subject of further study. Because of the same stereochemistry of the 3,5-dihydroxy hexanoate ester product and the chiral side chain of statin drugs, perhaps the enzyme functions in the biosynthesis of secondary metabolites with chiral hexanoate chains.
The biocatalytic synthesis of chiral side chain of statin drugs has been an extremely competitive area in which a number of approaches and routes have been reported 7-9 . A simple enzymatic process for the preparation of statin side chain can offer great potential in improving productivity of statins. To examine the utility of rDKR for such process, we tested 3,5-diketo ester at different concentrations with 5% ethanol as a co-solvent. As shown in Table 1 , the conversion reached almost completion at 2 mg/ml substrate concentration although there is an obvious negative correlation between substrate concentration and conversion rate. At 10 mg/ml substrate level, increase of the enzyme amount, in terms of activity, by as much as 10 fold and extension of the reaction time for 3 times did not affect the product yield, indicating a typical product inhibition by the 3,5-dihydroxy product. Meanwhile, it should be noted that there were no detectable monohydroxy products after 18 hours in all cases, which ruled out the possibility of inhibition by the intermediate monohydroxy compounds. Since the substrate is poorly water soluble, co-solvent is necessary for the biocatalytic systems. We, therefore, evaluated different co-solvents and their concentrations. Five percent of ethanol gave the best results compared with other solvents, such as DMSO, DMF, and lower or higher concentrations of ethanol, which may be attributable to the combination of enzyme tolerance to a particular concentration of the organic solvent and the reasonable substrate solubility in the reaction system. Based on the availability of directed evolution for protein engineering [29] [30] [31] , combining the potential of utilizing this unique enzyme for the preparation of chiral side chains of statin drugs, the issues of organic solvent tolerance and product inhibition with this enzyme and biocatlytic process would be feasibly solved [32] [33] [34] [35] . With a variety of mutants that are being generated, we will be able to utilize this enzyme to develop a practical and more economic route, compared to other biocatalytic approaches 9, 36-39 , to make statin drugs with industrial utility.
METHODS SUMMARY
Acinetobacter baylyi ATCC 33305 was grown in LB medium at 28 °C and 220 rpm for 48 hours. Two-stage fermentation was performed to obtain cells for bioconversion.
Heterogeneous expression of rDKR. The genomic DNA was extracted using a standard phenol-chloroform method. Degenerate PCR primers based on the peptide sequences were used to amplify the gene from A. baylyi ATCC 33305 genomic DNA.
The PCR product was purified and labeled with digoxigenin to hybridize with the Enzyme assay. Spectrophotometric method was used to assay the DKR activity at 40 °C by measuring the absorbance change at 340 nm for the oxidation of NADH or NADPH. The experiments for enzyme purification, temperature and pH optima, HMG-CoA as substrate, inhibition by calcium atorvastatin and kinetic analyses were also conducted by the spectrophotometric assay.
Purification of rDKR.
Frozen E coli cells were suspended in potassium phosphate buffer (pH 7.0) containing 1 mM DTT and 5% glycerol, and disrupted by passing through a high pressure cell press to yield cell-free extract. The cell-free extract was applied onto a DEAE-sepharose column equilibrated with a potassium phosphate buffer (pH 8.0).
After washing, the column was eluted with a linear gradient of 0-0.5 M NaCl. After concentration and desalting of the active fractions, the concentrated enzyme was applied onto a Sephadex G-100 column and eluted with a potassium phosphate buffer (pH 7.0). Same conditions were used as Fig. 2A . The peak at 23.6 was the (3R,5S)-stereoisomer of the dihydroxy ester product. The reactions were carried out at 28 °C and 220 rpm for 18 hours. The diastereomeric excess (de) and enantiomeric excess (ee) values were determined on Chiralcel OD-RH column using the same conditions as Fig. 2A .
Determination of cofactor effects.

